Solvonis Therapeutics says 1,093,333,333 further shares admitted

Solvonis Therapeutics said 1,093,333,333 ordinary shares were admitted, taking total shares in issue to 7,899,736,826. The company said none are held in treasury and the figure can be used as the denominator for voting-rights notifications.